"10.1371_journal.pone.0016780","plos one","2011-02-08T00:00:00Z","Luis Alberto García Rodríguez; Antonio González-Pérez; Héctor Bueno; John Hwa","Centro Español de Investigación Farmacoepidemiológica (CEIFE), Madrid, Spain; Departamento de Genómica Estructural, Neocodex SL, Sevilla, Spain; Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America","Conceived and designed the experiments: LAGR AG-P. Performed the experiments: LAGR AG-P. Analyzed the data: LAGR AG-P JH. Wrote the paper: LAGR AG-P JH HB.","I have read the journal's policy and have the following conflicts: CEIFE has received unrestricted research grants from Bayer and Pfizer in the last five years. Dr. Bueno reports having received consulting fees from Almirall, Bayer, BMS, and Sanofi-Aventis, and research grants from Astra-Zeneca, BMS, and Pfizer. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.","2011","02","Luis Alberto García Rodríguez","LAGR",4,TRUE,2,2,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
